Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khalil Zaman

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|October 11, 2019
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitorsElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2020
Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into AccountElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Revue Medicale Suisse|July 5, 2005
[Present chemoprevention and future vision]Isabel Filges, Khalil Zaman, Olivier Michielin, et al.
Journal of Bone Oncology|August 4, 2020
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252)Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Current Molecular Medicine|December 20, 2003
The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trialsCurzio Rüegg, Jean-Yves Meuwly, Robert Driscoll, et al.
Biomarkers in Medicine|September 4, 2015
Therapeutic drug monitoring of targeted anticancer therapyLaurent A Decosterd, Nicolas Widmer, Khalil Zaman, et al.
Revue Medicale Suisse|November 4, 2020
[Risk communication in healthcare: literature review and recommendations for clinical practice]Marie-Anne Durand, Kevin Selby, Patrick Bodenmann, et al.
Clinical Breast Cancer|December 20, 2020
Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature ReviewCamille Kopetti, Clara Schaffer, Khalil Zaman, et al.
Frontiers in Oncology|January 9, 2019
Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer HeterogeneityPelagia G Tsoutsou, Khalil Zaman, Silvia Martin Lluesma, et al.
Revue Medicale Suisse|October 30, 2025
[Breast cancer screening in Switzerland : organised, opportunistic, or opting out ?]Romain Freund, Rami Hajri, Murielle Bochud, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|October 11, 2019
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitorsElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2020
Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into AccountElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Revue Medicale Suisse|July 5, 2005
[Present chemoprevention and future vision]Isabel Filges, Khalil Zaman, Olivier Michielin, et al.
Journal of Bone Oncology|August 4, 2020
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252)Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Current Molecular Medicine|December 20, 2003
The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trialsCurzio Rüegg, Jean-Yves Meuwly, Robert Driscoll, et al.
Biomarkers in Medicine|September 4, 2015
Therapeutic drug monitoring of targeted anticancer therapyLaurent A Decosterd, Nicolas Widmer, Khalil Zaman, et al.
Revue Medicale Suisse|November 4, 2020
[Risk communication in healthcare: literature review and recommendations for clinical practice]Marie-Anne Durand, Kevin Selby, Patrick Bodenmann, et al.
Clinical Breast Cancer|December 20, 2020
Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature ReviewCamille Kopetti, Clara Schaffer, Khalil Zaman, et al.
Frontiers in Oncology|January 9, 2019
Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer HeterogeneityPelagia G Tsoutsou, Khalil Zaman, Silvia Martin Lluesma, et al.
Revue Medicale Suisse|October 30, 2025
[Breast cancer screening in Switzerland : organised, opportunistic, or opting out ?]Romain Freund, Rami Hajri, Murielle Bochud, et al.
Pageof 10